SAS Output

18-JUN-2018 6:10

BREAST ACCRUAL REPORT - Open and Recently Closed Studies

The REPORT Procedure

Detailed and/or summarized report

Table 1

SWOG/
Support
STUDY R
E
G
O
P
E
N
ARM ACCR.
GOAL
TOTAL
REGS.
REGS.
LAST
12
Month
REGS.
LAST
6
Month
REGS.
LAST
3
Month
REGS.
LAST
30
DAYS
REGS.
LAST
7
DAYS
DATE OF
FIRST
REG.
# of
ACT.
INSTs
# of
CURR
IRBs
SWOG S1007-Breast,Adj,N1,Endocrine+/-Chemo 1 Y 1 Recurrence Score testing 9400 9383 204 0 0 0 0 02/28/2011 446 208
            9383 204 0 0 0 0      
 
    2 Y 2 Chemo and Endocrine Therapy 5000 2547 76 0 0 0 0 02/28/2011    
        3 Endocrine Therapy Alone   2536 78 0 0 0 0      
            5083 154 0 0 0 0      
 
  S1207-Brst,Adj,Endocrine+/-Everolimus 1 Y 1 Blinded drug + Endocrine 1900 808 181 91 46 12 1 09/12/2013 461 234
        2 Blinded drug + Endocrine   817 193 92 49 13 5      
            1625 374 183 95 25 6      
 
  S1222-Brst,Fulv. +/- Ever. +/- Anastr. 1 T 1 Blinded treatment 840 12 0 0 0 0 0 05/15/2014 22 6
        2 Blinded treatment   12 0 0 0 0 0      
        3 Blinded treatment   13 0 0 0 0 0      
            37 0 0 0 0 0      
 
  S1416-Brst, TNBC/BRCA, Cis+/- ABT-888 1 Y 1 Blinded Drug + Cisplatin 333 123 76 28 9 0 0 09/15/2016 279 133
        2 Blinded Drug + Cisplatin   121 74 26 8 0 0      
            244 150 54 17 0 0      
 
  S1418-Breast, Adj, TNBC, MK-3475 (Pembrolizumab) 1 Y 1 Tissue for PD-L1 testing 1000 242 207 119 62 17 6 01/18/2017 432 202
            242 207 119 62 17 6      
 
    2 Y 2 Observation 1000 106 90 49 29 10 2 01/18/2017    
        3 MK-3475 (Pembrolizumab)   102 86 53 24 11 1      
            208 176 102 53 21 3      
 
Yes A011106-Breast, Neoadj, ALTERNATE study 1 E Total Registrations   59 21 8 6 2 0 04/29/2014 264 122
            59 21 8 6 2 0      
 
  E1Z11-Brst,Genetic Predictors of AIMSS 1 E Total Registrations   150 8 4 1 0 0 08/13/2013 189 69
            150 8 4 1 0 0      
 
No A011202-Breast, Nodal XRT +/- ALND 0 E Total Registrations   177 56 24 14 5 1 03/20/2014 402 208
            177 56 24 14 5 1      
 
    1 E Total Registrations   72 23 11 8 3 2 03/20/2014    
            72 23 11 8 3 2      
 
  A011401-Breast, adj, Stage II/III HER2-, weight loss 1 E Total Registrations   147 102 55 27 10 2 10/05/2016 442 238
            147 102 55 27 10 2      
 
    2 E Total Registrations   131 99 51 27 10 6 10/05/2016    
            131 99 51 27 10 6      
 
  A011502-Brst, Adj, Nodal+&HER2-, Aspirin vs. Placebo 1 E Total Registrations   46 42 24 17 5 1 03/20/2017   223
            46 42 24 17 5 1      
 
  A221405-Breast, ET interruption, Pregnancy Outcomes 1 E Total Registrations   9 7 1 0 0 0 05/08/2017   64
            9 7 1 0 0 0      
 
  B51-Breast, Regional Nodal XRT 1 E Total Registrations   27 13 4 2 2 1 06/13/2014 425 221
            27 13 4 2 2 1      
 
  B55-Brst, Adj Olaparib for BRCA,TNBC 1 E Total Registrations   59 18 10 4 1 0 12/15/2014 443 185
            59 18 10 4 1 0      
 
    2 E Total Registrations   26 8 4 3 1 0 12/15/2014    
            26 8 4 3 1 0      
 
  E2112-Brst,Adv,Exemestane+/-Entinostat 1 E Total Registrations   50 16 7 4 1 0 04/01/2015 296 165
            50 16 7 4 1 0      
 
  EA1131-Brst, TNBC, Post-op Chemo vs Obs 0 E Total Registrations   18 8 3 2 0 0 11/12/2015 300 130
            18 8 3 2 0 0      
 
    1 P Total Registrations   11 9 4 3 0 0 11/12/2015    
            11 9 4 3 0 0      
 
  EA1151-Brst, Tomosynthesis Mammographic Screening 1 E Total Registrations   108 108 108 83 28 6 01/30/2018   54
            108 108 108 83 28 6      
 
  NRGBR002-Brst, OMBC, II-III, SoC +/- SBRT and/or SA 1 E Total Registrations   1 1 0 0 0 0 09/22/2017   135
            1 1 0 0 0 0      
 
  NRGBR003-Brst,Adj,TNBC,AC -> WP +/- Carbo 1 E Total Registrations   56 20 8 7 0 0 10/16/2015 441 215
            56 20 8 7 0 0